| Literature DB >> 34950430 |
Jian Wan1, Xiao-Qi Yuan1, Tian-Qi Wu1, Mu-Qing Yang1, Xiao-Cai Wu1, Ren-Yuan Gao1, Lu Yin1, Chun-Qiu Chen2.
Abstract
BACKGROUND: Although minimally invasive surgery is becoming more commonly applied for ileostomy reversal (IR), there have been relatively few studies of IR for patients with Crohn's disease (CD). It is therefore important to evaluate the potential benefits and risks of laparoscopy for patients with CD. AIM: To compare the safety, feasibility, and short-term and long-term outcomes of laparoscopic IR (LIR) vs open IR (OIR) for the treatment of CD.Entities:
Keywords: Crohn’s disease; Enterolysis; Faster recovery; Ileostomy reversal; Intestinal adhesion; Laparoscopy
Year: 2021 PMID: 34950430 PMCID: PMC8649567 DOI: 10.4240/wjgs.v13.i11.1414
Source DB: PubMed Journal: World J Gastrointest Surg
Figure 1Laparoscopic ileostomy reversal and open ileostomy reversal. A: The intraperitoneal adhesions at the stoma were separated; B: The distal intestinal stump was separated; C: Separation was completed under laparoscopy; D and E: Abdominal incision of laparoscopic ileostomy reversal; F and G: Abdominal incision of open ileostomy reversal.
Baseline characteristics
|
|
|
|
|
| Age, yr, mean (range) | 36.5 (18-70) | 39.8 (20-73) | NS |
| Gender, male | 36 | 8 | NS |
| BMI, kg/m2, mean ± SD | 20.2 ± 4.9 | 20.3 ± 2.9 | NS |
| ASA class | NS | ||
| I-II | 45 | 11 | |
| III-IV | 3 | 1 | |
| Duration of ileostomy, mo, mean ± SD (range) | 7.6 ± 6.8 (3-48) | 13.0 ± 18.5 (3-72) | NS |
| Disease duration, mo, mean ± SD (range) | 46.1 ± 48.7 (3-168) | 39.3 ± 33.5 (4-96) | NS |
| History of abdominal operation | 1.4 ± 0.7 | 1.4 ± 0.9 | NS |
| Hematologic examination | |||
| WBC (/L) | 5.2 ± 1.3 | 5.2 ± 1.0 | NS |
| CRP (mg/L) | 5.9 ± 8.9 | 8.9 ± 17.6 | NS |
| ESR (mm) | 15.4 ± 11.5 | 15.8 ± 6.9 | NS |
| ALB (g/L) | 45.4 ± 4.8 | 43.6 ± 4.0 | NS |
| Hb (g/L) | 134.0± 18.2 | 131.0 ± 16.0 | NS |
| PLT (/L) | 240.8 ± 105.6 | 206.3 ± 49.3 | NS |
| PT (s) | 11.5 ± 0.9 | 11.2 ± 0.8 | NS |
| APTT (s) | 29.3 ± 3.4 | 28.2 ± 4.0 | NS |
BMI: Body mass index; ASA: American Society of Anesthesiologists; WBC: White blood cell count; CRP: C-reactive protein; ESR: Erythrocyte sedimentation rate; ALB: Albumin; Hb: Hemoglobin; PLT: Platelets; PT: Prothrombin time; APTT: Activated partial thromboplastin time; NS: Not significant.
Operative data and short-term (30-d) outcomes
|
|
|
| ||||
|
|
|
|
|
|
|
|
| Operative time, min | 116.5 ± 38.4 | 117.1 ± 28.6 | NS | 128.2 ± 41.7 | 142.5 ± 41.7 | NS |
| Estimated blood loss, mL | 69.7 ± 93.1 | 71.4 ± 94.8 | NS | 73.1 ± 91.3 | 94.2 ± 88.1 | NS |
| Days to flatus, d, mean ± SD | 2.3 ± 0.6 | 1.7 ± 0.7 |
| 2.3 ± 0.8 | 2.0 ± 0.7 | NS |
| Days to soft diet, d, mean ± SD | 4.5 ± 1.7 | 2.7 ± 0.7 |
| 5.1 ± 3.9 | 3.8 ± 1.4 | NS |
| Total postoperative complication, | 3 (10) | 1 (14.3) | NS | 5 (10.4) | 2 (16.7) | NS |
| Anastomotic hemorrhage | 1 | 0 | 1 | 0 | ||
| Anastomotic leakage | 0 | 0 | 1 | 0 | ||
| Ileus | 0 | 0 | 1 | 0 | ||
| Wound infection | 1 | 1 | 2 | 2 | ||
| Reoperation | 0 | 0 | 0 | 0 | ||
| Readmission after discharge | 0 | 0 | - | 0 | 0 | - |
| Length of stay, d, mean ± SD (range) | 9.6 ± 2.7 (5-15) | 8.6 ± 2.8 (6-15) | NS | 10.3 ± 4.0 (5-32) | 10.8 ± 3.7(6-18) | NS |
| Cost (RMB) | 57967 | 37301 |
| 62916 | 52274 | NS |
NS: Not significant.
Figure 2Long-term outcomes after ileostomy reversal. The reoperation rate after ileostomy reversal was similar between laparoscopic ileostomy reversal and open ileostomy reversal. LIR: Laparoscopic ileostomy reversal; OIR: Open ileostomy reversal.